Product
Perillyl alcohol
Aliases
NEO100
1 clinical trial
1 indication
Indication
Glioblastoma MultiformeClinical trial
An Open-Label, Phase 1/2A Dose Escalation Study of Safety and Efficacy of NEO100 in Recurrent or Progressive Grade III or Grade IV Gliomas With IDH1 MutationStatus: Recruiting, Estimated PCD: 2024-06-01